Real-World Implications Of Her2 Low: The Major New Breast Cancer Designation And Its Treatment – How Low Is Too Low?

Fact Checked

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles. Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated December 22nd, 2022

Real-World Implications Of Her2 Low: The Major New Breast Cancer Designation And Its Treatment – How Low Is Too Low?

NOW
PLAYING
Saving Lives Urgently, The Major Cancer Advances Of The Year - What's Next For 2023?
NOW
PLAYING
What Do Doctors Look For As Patients Undergo Oral Treatment (TKIs) For CML?
NOW
PLAYING
Remembering The Beloved Olivia Newton-John: Singer, Who Lived With So Much Grace As She Fought Breast Cancer
NOW
PLAYING
Genetic Testing Can Help Determine Your Lung Cancer Treatment
NOW
PLAYING
For Some Advanced Breast Cancers Powered By Estrogen, The Drug Camizestrant Shows Promise Actually Degrading The Hormone
NOW
PLAYING
Newly FDA-Approved Drug Elahere May Be Effective Treatment For Patients With A Particularly Aggressive Form Of Ovarian Cancer

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... breast cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

Treatment: Lymphedema

SEE MORE   

Treatment: Lymphedema

Lymphedema is a chronic swelling that can occur after breast cancer surgery and radiation.

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.